Adicon Holdings Limited, an independent clinical laboratory in China backed by US global investment firm Carlyle, on Tuesday announced the completion of an $88 million funding round that will help it speed up its diagnostic testing business in the country.
The latest round, which had reached its first close late last year, was led by Malaysia’s sovereign wealth fund Khazanah Nasional Berhad with the participation of Korean investment firm Mirae Asset Global Investments.
